This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Zinc deficiency simultaneously impairs immune function (T-cell maturation via thymulin, NK activity, antimicrobial peptide production), mood (NMDA receptor and serotonergic modulation), skin integrity (keratinocyte differentiation, wound repair), and endocrine function (testosterone synthesis, T4 to T3 conversion, insulin signalling). UK SACN RNI is 9.5 mg/day men, 7 mg/day women. Severe deficiency presents with acrodermatitis-like rash, recurrent infection, and growth failure; subclinical deficiency may show as fatigue, hair changes, dysgeusia, and slow wound repair.
Zinc-dependent processes by system. Immune: thymulin synthesis (T-cell maturation), antimicrobial peptide production, NK cell function, neutrophil bactericidal activity. Neurological: NMDA receptor modulation, serotonergic and dopaminergic signalling, hippocampal zinc pools involved in memory and mood. Skin: keratinocyte differentiation, wound repair via matrix metalloproteinase regulation. Endocrine: testosterone synthesis (LH receptor signalling), thyroid hormone deiodinase function, insulin storage and signalling. Cellular handling via metallothionein binding and Zn-transporter (ZIP and ZnT family) regulation per Cousins 1985 (PMID 3885271).
Mild-to-moderate deficiency in non-malabsorbing adults usually responds to 25 mg/day elemental zinc over 8-12 weeks. Severe deficiency or malabsorption (IBD, post-bariatric surgery, acrodermatitis enteropathica) requires specialist regimens. WHO and UNICEF guidance for childhood diarrhoea: 10-20 mg/day zinc for 10-14 days. Replacement should be targeted to documented deficiency rather than presumed low-grade insufficiency, which the unreliability of serum zinc as a status test (entry 90c3c063) makes difficult to confirm objectively.
Read product labels for elemental zinc content as some list salt weight rather than elemental amount. For example, 220 mg zinc sulphate provides 50 mg elemental zinc. Topical zinc preparations have specific roles (zinc oxide for nappy rash, sunscreens) but do not address systemic deficiency.
Specific clinical features improve at different rates: dysgeusia (taste disturbance) and skin lesions often improve within 2-4 weeks; hair regrowth and immune markers over 8-16 weeks; testosterone restoration in deficient men over 8-24 weeks. Multi-system signs do not all respond in the same timeframe.
Copper-deficiency myelopathy and sideroblastic anaemia from chronic high zinc are well-documented (Hedera 2009 PMID 19732792 from denture creams; Irving 2003 PMID 12874162 reversible cytopenias from supplementation; Chun 2025 PMID 40700102). For routine deficiency replacement at 25 mg/day for 2-3 months, this risk is minimal; the risk is in chronic high-dose self-supplementation (50-100 mg/day for years). HDL cholesterol can fall on supraphysiological intake.
Pregnancy: SACN does not increase RNI for pregnancy beyond 9.5 mg/day, but maternal zinc deficiency is associated with poor birth outcomes; deficiency screening in clinically suspect cases is reasonable. Children with persistent diarrhoea benefit from short-course zinc per WHO and UNICEF protocol. Older adults often have multifactorial low-grade deficiency from reduced intake, reduced absorption, and increased losses; routine supplementation is not standard but may be appropriate in documented deficiency.
Phytate (in unprocessed legumes, whole grains, nuts) is the major dietary inhibitor of zinc absorption; this matters for vegetarian and vegan adults. Cooking and processing methods (soaking, sprouting, fermentation, leavening with yeast) reduce phytate and improve zinc bioavailability. Animal-source foods provide more bioavailable zinc per unit weight than plant sources.
Authoritative reviews: Hambidge and Krebs 2005 (Am J Clin Nutr supplement, PMID 16373942) on the global deficiency framework; Prasad 2012 (J Trace Elem Med Biol, PMID 22664333) on the discovery and clinical history of human zinc deficiency. UK NICE does not publish standalone zinc guidance; deficiency identification and replacement sit within general nutritional practice.
Multi-system clinical signs that justify trial replacement: persistent dysgeusia, slow wound repair, hair thinning or alopecia areata, recurrent skin or respiratory infection, unexplained fatigue or low mood with at least one nutritional risk factor. Combined response across more than one system within 8-12 weeks supports the deficiency hypothesis. Failure to respond should prompt reassessment rather than escalating dose. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.
Claim: equating zinc lozenge dosing for cold duration (75-100 mg per dose, short course) with chronic daily replacement (25 mg/day). The two protocols address different questions and have different safety profiles.
Claim: assuming dietary zinc from plant sources is bioavailable as animal-source zinc; phytate inhibition substantially reduces uptake and matters for vegetarian and vegan adults.
This entry is relevant for the following groups, conditions, and medication contexts: